ACTUATE THERAPEUTICS (ACTU) CFO receives 105,000 stock options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ACTUATE THERAPEUTICS, INC. Chief Financial Officer Paul J. Lytle received an equity compensation grant of employee stock options for 105,000 shares of common stock. The options have an exercise price of $2.49 per share and expire on April 1, 2036.
These options will vest 25% on April 1, 2027, with the remaining 75% vesting in equal monthly installments over the following 36 months. The filing reflects a compensation-related award rather than an open-market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
LYTLE PAUL J
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 105,000 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 105,000 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 105,000 options
Exercise price: $2.49 per share
Underlying shares: 105,000 shares
+3 more
6 metrics
Option grant size
105,000 options
Employee Stock Option grant to CFO
Exercise price
$2.49 per share
Strike price for underlying common stock
Underlying shares
105,000 shares
Common stock underlying the options
Options expiration
April 1, 2036
Final date to exercise options
Initial vesting tranche
25% on April 1, 2027
Cliff vesting date for first portion
Remaining vesting period
75% over 36 months
Monthly vesting following first anniversary
Key Terms
Employee Stock Option (right to buy), exercise price, grant date, vest, +1 more
5 terms
Employee Stock Option (right to buy) financial
"security_title: Employee Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 2.4900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
grant date financial
"following the first anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vest financial
"Options will vest as to 25% on April 1, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
derivative securities financial
"transaction_type: derivative"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
